Aether Bio is a biotechnology company headquartered in Menlo Park, California, that develops AI-designed molecular machines. Utilizing its Protein Function Model, the company accelerates protein discovery for advanced manufacturing, super materials, and critical mineral processing.
Subscribe to see Aether Bio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Aether Bio is a biotechnology company headquartered in United States. Its most recent funding round, Series A, closed in December 2025. Xcout tracks 2 named people at Aether Bio, including Pavle Jeremic (Founder & CEO).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | Undisclosed | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Aether Bio's closest competitors — see the full list of competitors and alternatives →
AbInitio Bio is developing the first foundation models specifically for biomanufacturing. The company is headquartered in San Francisco.
A-Alpha Bio is a synthetic biology and machine learning company that precisely engineers high-impact medicines by measuring millions of protein-protein interactions. Founded in 2017 as a spinout from the University of Washington, the company is based in Seattle.
Avenue Biosciences provides a machine learning-powered protein engineering platform designed to optimize secretory pathways for therapeutic protein manufacturing. The company serves biotechnology and pharmaceutical developers by enhancing the yield, quality, and production of difficult-to-express proteins, biologics, and gene therapies.
Noetik Inc. is an AI-native biotechnology company headquartered in South San Francisco, California, leveraging advanced machine learning methods for biological discovery.
Atomic AI is a biotechnology research company specializing in RNA drug discovery utilizing atomic precision. Headquartered in San Francisco, California, the company combines machine learning and biology to develop advanced therapeutics.
Molecule.one is a chemistry artificial intelligence company that develops autonomous discovery software for chemical research. Headquartered in Portola Valley, California, the company operates research and technical facilities to accelerate laboratory workflows.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.